冠脉CT多器官体成分分析预测心梗与死亡
本研究回顾性分析SCOT-HEART试验中1722例患者的冠脉CT大视野图像,使用TotalSegmentator模型自动分割多器官并计算体积与平均衰减。多变量Cox回归显示骨骼肌衰减与全因死亡及心肌梗死风险独立相关,多器官体成分分析可提供额外预后信息。
要点
- 骨骼肌衰减低于中位者死亡风险HR为1.85,心梗风险HR为1.58。
- 多器官体成分分析可为冠脉CT报告增加预后分层价值。
核心结论
- 冠脉CT多器官体成分分析可提供超出冠脉发现的预后信息。
- 骨骼肌衰减是其中最重要的体成分预后指标。
- 骨骼肌衰减低于中位数者死亡和心梗风险均显著升高。
研究设计与样本
- 研究类型为回顾性队列研究,嵌套于SCOT-HEART多中心随机对照试验。
- 共纳入1722例患者(2010年11月至2014年9月招募),平均年龄57.5岁±9.5,男性占55.7%。
- 使用TotalSegmentator深度学习模型对冠脉CT大视野图像进行多器官自动分割。
- 参考标准为10年随访期间的全因死亡和心肌梗死事件。
关键影像表现/征象
- 冠心病患者表现为肺衰减增高(OR 1.04,95%CI 1.03-1.06,P<.001)。
- 冠心病患者表现为肝脏衰减降低(OR 0.87,95%CI 0.8-0.95,P=.034)。
- 冠心病患者表现为躯干脂肪体积增大(OR 1.01,95%CI 1.01-1.02,P<.001)。
- 心肌梗死与心肌体积增大(HR 1.09,95%CI 1.01-1.16,P=.018)相关。
- 心肌梗死与肋骨衰减降低(HR 0.98,95%CI 0.96-1.0,P=.043)相关。
诊断标准与关键数值
- 骨骼肌衰减每增加10单位,全因死亡HR为0.61(95%CI 0.47-0.79,P<.001)。
- 骨骼肌衰减每增加10单位,心肌梗死HR为0.69(95%CI 0.54-0.87,P=.002)。
- 进一步校正冠脉钙化积分后,骨骼肌衰减仍与心梗相关(HR 0.72,95%CI 0.57-0.91,P=.007)。
- 骨骼肌衰减低于中位数者死亡HR为1.85(95%CI 1.30-2.64,P<.001)。
- 骨骼肌衰减低于中位数者心梗HR为1.58(95%CI 1.07-2.33,P=.022)。
临床应用与阅片要点
- 阅片时可关注骨骼肌衰减值,低于中位数者提示预后较差。
- 利用大视野冠脉CT图像进行多器官体成分自动分割具有临床可行性。
- 报告冠脉CT时可将骨骼肌衰减作为补充预后指标。
局限性
- 多变量模型未校正全部潜在混杂因素,仅校正年龄、性别和扫描长度。
- 与冠脉钙化积分联合调整后仅骨骼肌衰减保持与心梗显著相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Coronary CT angiography provides prognostic information in addition to coronary findings. Purpose To evaluate associations between machine learning-derived multiorgan body composition and 10-year outcomes in the SCOT-HEART (Scottish Computed Tomography of the Heart) trial. Materials and Methods Wide field-of-view images of 1722 patients (recruited between November 2010 and September 2014) were retrospectively processed using the TotalSegmentator model. The volume and mean attenuation of segmented organs were calculated. Multivariable Cox proportional hazards models were constructed for all-cause mortality and myocardial infarction (MI), adjusted for age, sex, and scan length. Odds ratios or hazard ratios (HRs) and 95% CIs were calculated per 10-unit increase in attenuation or volume. Results Mortality and MI occurred in 133 (7.72%) and 106 (6.16%) of the 1722 patients, respectively (age, 57.5 years ± 9.5 [SD]; 55.7% male). Coronary artery disease was associated with greater lung attenuation (odds ratio, 1.04 [95% CI: 1.03, 1.06]; P < .001), lower liver attenuation (odds ratio, 0.87 [95% CI: 0.8, 0.95]; P = .034), and greater torso fat volume (odds ratio, 1.01 [95% CI: 1.01, 1.02]; P < .001) after multivariable adjustment. Increased skeletal muscle attenuation was associated with lower all-cause mortality (HR, 0.61 [95% CI: 0.47, 0.79]; P < .001) after multivariable adjustment. MI was associated with increased myocardial volume (HR, 1.09 [95% CI: 1.01, 1.16]; P = .018) and decreased rib (HR, 0.98 [95% CI: 0.96, 1.0]; P = .043) and skeletal muscle (HR, 0.69 [95% CI: 0.54, 0.87]; P = .002) attenuation after multivariable adjustment. However, when further adjusted for coronary calcium score, only skeletal muscle attenuation was associated with MI (HR, 0.72 [95% CI: 0.57, 0.91]; P = .007). Patients with skeletal muscle attenuation below the median had a higher risk of mortality (HR, 1.85 [95% CI: 1.30, 2.64]; P < .001) or experience MI (HR, 1.58 [95% CI: 1.07, 2.33]; P = .022). Conclusion Multiorgan body composition analysis using coronary CT angiography provided additional prognostic information, among which skeletal muscle attenuation was particularly important. ClinicalTrials.gov identifier: NCT01149590 © RSNA, 2026 Supplemental material is available for this article.
引用
- Guimaraes, Williams, Macmillan, et al. Machine Learning Multiorgan Analysis of Coronary CT Angiography Body Composition, Myocardial Infarction, and Mortality in the SCOT-HEART Trial. Radiology. 2026. PMID: 42377128. doi:10.1148/radiol.251821
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。